RedHill Biopharma Balance Sheet (2011-2025) | RDHL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Receivables - Notes (Quarter)																				0.03M
Assets
Current Assets
Cash & Equivalents (Quarter)	29.02M	81.61M	81.61M	29.02M	29.30M	75.97M	75.97M	51.82M	29.47M	29.47M	29.47M	29.47M	19.97M	17.57M	19.97M	5.57M	7.28M	4.62M	4.62M	3.97M
Receivables - Net (Quarter)	1.22M				28.66M				31.68M				34.52M			2.59M		2.54M		0.08M
Receivables - Other (Quarter)											1.87M				1.34M					3.13M
Receivables (Quarter)	1.22M				28.66M				31.68M				34.52M			2.59M		2.54M		3.21M
Raw Materials (Quarter)	1.59M				1.79M				3.01M				1.80M			0.83M		0.51M
Work In Process (Quarter)									5.20M				2.38M			0.23M		0.31M
Finished Goods (Quarter)	0.29M				4.73M				6.60M				6.83M			3.33M		2.83M
Inventory (Quarter)	1.88M	2.77M	4.75M	5.10M	6.53M	9.27M	8.76M	13.12M	14.81M	14.27M	11.72M	12.58M	11.01M	5.86M	4.94M	4.39M	3.80M	3.65M	3.17M
Prepaid Assets (Quarter)	2.24M	1.60M	4.87M	4.63M	5.52M	4.09M	4.29M	4.68M	4.66M	3.51M	2.79M	3.29M	4.39M	5.17M	3.05M	2.80M	2.91M	1.10M	1.01M	2.48M
Current Assets (Quarter)	53.21M		61.13M		70.50M		98.49M		89.15M		91.27M		85.90M		27.05M	16.14M	15.70M	11.91M	12.55M	6.53M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.23M	0.36M	0.34M	0.47M	0.51M	0.55M	0.51M	0.48M	0.57M	0.53M	0.62M	0.57M	0.50M	0.44M	0.24M	0.19M	0.15M	0.14M	0.13M	0.05M
Long-Term Investments (Quarter)																				12.05M
Intangibles (Quarter)	-0.22M	15.85M	79.52M	89.96M	5.76M	86.05M	84.22M	82.39M	-0.12M	70.04M	68.74M	67.14M	-29.36M	5.60M	5.59M	-0.18M	5.56M	5.55M	5.53M	5.29M
Goodwill & Intangibles (Quarter)	-0.22M	15.85M	79.52M	89.96M	5.76M	86.05M	84.22M	82.39M	-0.12M	70.04M	68.74M	67.14M	-29.36M	5.60M	5.59M	-0.18M	5.56M	5.55M	5.53M	5.29M
Long-Term Deferred Tax (Quarter)		1.18M
Other Non-Current Assets (Quarter)	0.15M	20.15M	20.15M	16.15M	16.16M	16.16M	16.16M	16.16M	16.17M	16.16M	16.00M	16.00M	16.00M	11.05M	9.14M	0.79M	0.74M	0.15M	0.16M	0.17M
Non-Current Assets (Quarter)	20.89M		105.24M		109.75M		105.18M		92.04M		76.70M		72.97M		7.99M	6.91M	6.32M	6.13M	5.82M	18.82M
Assets (Quarter)	74.10M	143.48M	166.37M	168.98M	180.24M	220.12M	203.67M	186.34M	181.19M	167.05M	167.97M	157.19M	158.87M	58.83M	35.04M	23.05M	22.02M	18.04M	18.38M	25.34M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.18M	3.19M	5.31M	6.57M	11.55M	6.54M	13.31M	15.24M	11.66M	5.71M	4.37M	4.78M	4.23M	4.37M	3.11M	3.28M	1.91M	1.17M	0.83M	0.73M
Notes Payables (Quarter)													115.22M
Payables (Quarter)	4.18M	3.19M	5.31M	6.57M	11.55M	6.54M	13.31M	15.24M	11.66M	5.71M	4.37M	4.78M	119.45M	4.37M	3.11M	3.28M	1.91M	1.17M	0.83M	0.73M
Accumulated Expenses (Quarter)	4.33M	12.91M	29.19M	23.54M	24.08M	25.45M	23.16M	20.59M	20.90M	24.15M	20.21M	21.20M	17.95M	17.13M	7.40M	4.59M	3.96M	9.99M	10.69M	12.02M
Other Accumulated Expenses (Quarter)	0.50M	0.50M	0.50M	0.50M	0.75M	0.75M	0.75M	0.75M	0.75M	0.75M	0.75M	0.75M	0.75M	0.75M	0.75M	0.54M	0.54M	0.50M	0.50M	0.50M
Short term Debt (Quarter)													115.22M
Current Leases (Quarter)	0.83M				1.71M				1.62M				1.03M			0.72M		0.35M		0.17M
Current Deferred Revenue (Quarter)	1.27M	-0.33M	-1.09M	0.51M	18.34M	22.68M	26.10M	28.36M	30.71M	31.39M	39.22M	41.78M	17.16M	25.97M	-31.49M	-37.22M	12.45M	-1.37M	10.54M	-2.98M
Total Current Liabilities (Quarter)	10.62M		35.87M		73.23M		79.17M		81.47M		166.41M		197.45M		28.19M	19.98M	21.23M	22.22M	22.29M	19.22M
Non-Current Liabilities
Non-Current Debt (Quarter)		78.17M	79.19M	80.27M	81.39M	82.52M	83.16M	83.52M	83.62M	86.40M	85.51M	113.86M	115.22M
Non-Current Deffered Revenue (Quarter)	0.50M				0.75M				0.75M				0.75M			0.54M
Operating Leases (Quarter)	2.98M	3.84M	4.04M	4.08M	3.81M	3.39M	2.98M	2.85M	2.57M	7.18M	6.67M	6.01M	6.44M	6.01M	1.29M	0.72M	0.37M	0.35M	0.21M	0.90M
Other Non-Current Liabilities (Quarter)																				0.46M
Total Non-Current Liabilities (Quarter)	3.48M		95.91M		93.14M		94.92M		90.84M		13.49M		9.82M		3.38M	0.99M	0.73M	0.50M	0.50M	1.86M
Total Liabilities (Quarter)	14.10M	99.83M	131.78M	140.24M	166.38M	167.08M	174.09M	174.79M	172.31M	172.29M	179.91M	203.22M	2.62M	56.83M	31.57M	0.74M	21.96M	22.73M	22.79M	21.08M
Shareholder's Equity
Total Debt (Quarter)		78.17M	79.19M	80.27M	81.39M	82.52M	83.16M	83.52M	83.62M	86.40M	85.51M	113.86M	230.43M
Common Equity (Quarter)	60.00M	43.65M	34.59M	28.75M	13.86M	53.04M	29.58M	11.55M	8.88M	-5.24M	-11.94M	-46.03M	-48.40M			2.07M	0.06M	-4.68M	-4.41M	4.27M
Liabilities and Shareholders Equity (Quarter)	74.10M	143.48M	166.37M	168.98M	180.24M	220.12M	203.67M	186.34M	181.19M	167.05M	167.97M	157.19M	158.87M	58.83M	35.04M	23.05M	22.02M	18.04M	18.38M	25.34M
Retained Earnings (Quarter)	-208.36M	-224.72M	-240.14M	-257.08M	-280.33M	-302.32M	-326.17M	-345.37M	-367.87M	-382.70M	-397.18M	-431.27M	-433.86M	-383.48M	-382.01M	-407.74M	-410.06M	-414.80M	-418.12M	-413.75M

Research Tools

Developers

RedHill Biopharma Balance Sheet (2011-2025) | RDHL

Research Tools

Developers

RedHill Biopharma Balance Sheet (2011-2025) | RDHL

Create an account

Sign In

Reset Password